|Last Price$31.12||Day Change (%)0.84%|
|Open Price$30.83||Day Change ($)0.26|
|Day Range30.69–31.40||52-Week Range28.50–37.44|
As of Fri 7/31/2015 5:52:00 PM | USD
Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE™ (ombitasvir, paritaprevir and ritonavir) tablets
Though midstream energy's shifting fundamentals challenge Boardwalk, these same changes create opportunities for the majority of pipeline operators we cover.
Marsico Capital CEO Tom Marsico favors the growth prospects of these biotech companies that are producing novel drugs for unmet medical needs.